Skip to main content
SpringerLink
Log in

COST measures financial toxicity in cancer patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. higher score = less financial toxicity

Reference

  • de Souza JA, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity. Cancer : 7 Oct 2016. Available from: URL: http://doi.org/10.1002/cncr.30369

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

COST measures financial toxicity in cancer patients. PharmacoEcon Outcomes News 765, 10 (2016). https://doi.org/10.1007/s40274-016-3495-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3495-1

Search

Navigation